immune checkpoint inhibitors

You have access
Immune Checkpoint Inhibitor-induced Uveitis: Disproportionality and Timing Analyses of the Japanese Pharmacovigilance Database
NAOHITO IDE, KEN-ICHI SAKO and TOMOJI MAEDA

Anticancer Research May 2025, 45 (5) 2215-2223; DOI: https://doi.org/10.21873/anticanres.17595
You have access
Comparative Analysis of Outcomes for Patients With Advanced Renal Cell Carcinoma: Immuno-Oncology Era Versus Tyrosine Kinase Inhibitor Era in the IMDC Favorable-risk Group
HIROKI ISHIHARA, YUKI NEMOTO, SHINSUKE MIZOGUCHI, KOICHI NISHIMURA, HIRONORI FUKUDA, KAZUHIKO YOSHIDA, HIROAKI SHIMMURA, YASUNOBU HASHIMOTO, JUNPEI IIZUKA, TSUNENORI KONDO and TOSHIO TAKAGI

Anticancer Research April 2025, 45 (4) 1643-1652; DOI: https://doi.org/10.21873/anticanres.17545
You have access
Efficacy and Safety of Nivolumab With Ipilimumab in Elderly Patients With Advanced Renal Cell Carcinoma
KOSUKE UEDA, NAOKI ITO, YUYA SAKAI, SATOSHI OHNISHI, TAISHI HIRANO, HIROFUMI KUROSE, KATSUAKI CHIKUI, KEIICHIRO UEMURA, KIYOAKI NISHIHARA, MAKOTO NAKIRI, SHIGETAKA SUEKANE and TSUKASA IGAWA

Anticancer Research November 2024, 44 (11) 5087-5093; DOI: https://doi.org/10.21873/anticanres.17333
Open Access
Systemic Inflammation Indexes and Risk of Immune-related Adverse Events in Patients With Metastatic Urothelial Carcinoma Treated With Immunotherapy
MICHELE DIONESE, DAVIDE BIMBATTI, FRANCESCO PIERANTONI, ELEONORA LAI, ELISA ERBETTA, NICOLÒ CAVASIN, SALIM JUBRAN, UMBERTO BASSO and MARCO MARUZZO

Anticancer Research October 2024, 44 (10) 4379-4386; DOI: https://doi.org/10.21873/anticanres.17267
You have access
Role of Hematological Markers in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Treated With Pembrolizumab
KOHEI HAGIWARA, TAKASHI MATSUKI, TAKURO OKADA, CHIHIRO FUSHIMI, TAKAHITO KONDO, HIDEAKI TAKAHASHI, ISAKU OKAMOTO, KUNIHIKO TOKASHIKI, KENJI HANYU, TAKUMA KISHIDA, TATSUYA ITO, GAI YAMASHITA, KIYOAKI TSUKAHARA, TATSUO MASUBUCHI, YUICHIRO TADA, KAHO MOMIYAMA, RYOHEI YAGUCHI, NOBUHIKO ORIDATE, GO OMURA and TAKU YAMASHITA

Anticancer Research September 2024, 44 (9) 4057-4072; DOI: https://doi.org/10.21873/anticanres.17235
Open Access
Maximum Efficacy of Immune Checkpoint Inhibitors Occurs in Esophageal Cancer Patients With a Low Neutrophil-to-Lymphocyte Ratio and Good Performance Status Prior to Treatment
YUYA HIRASAWA, YUTARO KUBOTA, EMIKO MURA, RISAKO SUZUKI, TOSHIAKI TSURUI, NANA IRIGUCHI, TOMOYUKI ISHIGURO, RYOTARO OHKUMA, MASAHIRO SHIMOKAWA, HIROTSUGU ARIIZUMI, ATSUSHI HORIIKE, SATOSHI WADA, TOMOTAKE ARIYOSHI, SATORU GOTO, KOJI OTSUKA, MASAHIKO MURAKAMI, YUJI KIUCHI, KIYOSHI YOSHIMURA, ROBERT M. HOFFMAN and TAKUYA TSUNODA

Anticancer Research August 2024, 44 (8) 3397-3407; DOI: https://doi.org/10.21873/anticanres.17160
You have access
Efficacy of Immune Checkpoint Inhibitors in Postoperative Recurrence of Wild-type EGFR Non-Small Cell Lung Cancer
YOSHITO IMAMURA, TAKETO KATO, YUJI NOMATA, SHOJI OKADO, HIROKI WATANABE, YUTA KAWASUMI, KEITA NAKANISHI, YUKA KADOMATSU, HARUSHI UENO, SHOTA NAKAMURA, TETSUYA MIZUNO, TETSUNARI HASE, ICHIDAI TANAKA, MAKOTO ISHII, HIROSHI YATSUYA and TOYOFUMI FENGSHI CHEN-YOSHIKAWA

Anticancer Research August 2024, 44 (8) 3451-3461; DOI: https://doi.org/10.21873/anticanres.17165
You have access
Local Low-dose Anti-PD-L1 Antibodies Improve Antitumor Effects in Oral Squamous Cell Carcinoma
TOKO MACHIDA, KANAME SAKUMA, NOBUKAZU FUWA and AKIRA TANAKA

Anticancer Research March 2024, 44 (3) 993-1002; DOI: https://doi.org/10.21873/anticanres.16894
You have access
Clinicopathological and Molecular Characteristics Promoting PD-L1 Expression in Early-stage Lung Adenocarcinoma and Squamous Cell Carcinoma
ATSUSHI ITO, TOMOHITO TARUKAWA, YUTA SUZUKI, TADASHI SAKAGUCHI, KENTARO ITO, KENTARO FUJIWARA, YOICHI NISHII, OSAMU TAGUCHI, HIROKI YASUI, MOTOSHI TAKAO and OSAMU HATAJI

Anticancer Research November 2023, 43 (11) 5197-5204; DOI: https://doi.org/10.21873/anticanres.16721
Open Access
PD-L1 mRNA Detection in Immunohistochemically Negative Patients: A Complementary Method for a Better Treatment Selection?
ULRICH SOMMER, MARIANNE GROSSER, DANIELA AUST, KORINNA JOEHRENS, KATHARINA BOEHM, CHRISTIAN THOMAS, PIA HOENSCHEID, HOLGER H.H. ERB and GUSTAVO B. BARETTON

Anticancer Research October 2023, 43 (10) 4365-4371; DOI: https://doi.org/10.21873/anticanres.16632

Main menu

User menu

Search

immune checkpoint inhibitors

Pages